- Telehealth visits
Sarah Coates, MD
She | Her | HersPediatric Dermatology- Telehealth visits
Sarah Coates, MD
She | Her | HersPediatric Dermatology- Telehealth visits
On this page
About me
Dr. Sarah Coates is a dermatologist who cares for children with all types of skin conditions. She also works at Zuckerberg San Francisco General Hospital and Trauma Center, caring for adults living with HIV. Her special interests include infectious diseases, social determinants of health and Kaposi's sarcoma (a cancerous condition of immunosuppressed people).
In her research, Coates studies ways to optimize diagnosis of Kaposi's sarcoma, which predominantly affects people who are HIV positive. She has extensive experience in global health dermatology and has spent time working in East Africa since 2011. She received a Fogarty fellowship from the National Institutes of Health to study Kaposi's sarcoma at the Infectious Diseases Institute in Kampala, Uganda.
Coates earned her medical degree at the Weill Cornell Graduate School of Medical Sciences. She completed a residency in dermatology and a fellowship in pediatric dermatology at UCSF.
Education & training
Board certification
- Pediatric Dermatology, American Board of Dermatology
- Dermatology, American Board of Dermatology
Fellowship
- Pediatric Dermatology, University of CA at San Francisco- Dermatology GME
Residency
- Dermatology, University of CA at San Francisco- Dermatology GME
Internship
- Internal Medicine, Providence Portland Medical Center
Degree
- MD, Weill Cornell Graduate School of Medical Sciences
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.